Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rang in Aktien #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aktienkurs
$48.45
Marktkapitalisierung
$1.39B
Veränderung (1 Tag)
1.16%
Veränderung (1 Jahr)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategorie

Kursverlauf für LB Pharmaceuticals Inc Common Stock (LBRX)
Höchster Schlusskurs: $47.36 am 2026-08-01

Niedrigster Schlusskurs: $15.87 am 2025-09-01
Kursverlauf der Aktie von LB Pharmaceuticals Inc Common Stock von 2025 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 24.35%
2025 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH